# Liposomal Bupivacaine vs Dexamethasone ISB

> **NCT04047446** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 112 (actual)

## Conditions studied

- Shoulder Pain

## Interventions

- **DRUG:** Exparel 133 MG Per 10 ML Injection
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04047446
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-11
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-03-19
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04047446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04047446, "Liposomal Bupivacaine vs Dexamethasone ISB". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04047446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*